Over the past 20 years there has been a concerted effort to use reliable evidence in making decisions about health care. The Effective Health Care Research Consortium (EHCRC) aims to improve the evidence base and ensure its dissemination. The EHCRC helps to ensure that healthcare problems relevant to low- and middle-income countries are addressed, and that people living in these countries are part of the process.
Two job vacancies in evidence synthesis at the CIDG
06 September 2018
Primary antifungal prophylaxis for cryptococcal disease in HIV‐positive people
Published: 29 August 2018
Xpert® MTB/RIF assay for extrapulmonary tuberculosis and rifampicin resistance
Published: 28 August 2018
Drugs for treating Buruli ulcer (Mycobacterium ulcerans disease)
Published: 24 August 2018
Treatment for HIV‐associated cryptococcal meningitis.
Published: 25 July 2018
Since 1994, the Cochrane Infectious Diseases Group (CIDG) has been preparing systematic reviews on the benefits and harms of healthcare interventions for infectious diseases, in particular malaria, tuberculosis, diarrhoea, and tropical diseases. The CIDG editorial base is located at the Liverpool School of Tropical Medicine in Liverpool, UK. The CIDG is part of the EHCRC. The EHCRC, which is funded by UK aid from the UK Government for the benefit of developing countries, is the main funder of the CIDG.